• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Spermatogenesis-associated protein 5 (SPATA5), Truncated

ACP12784

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP12784 Target NameSPATA5
Target SynonymsSPATA5; AFG2; SPAF; ATPase family protein 2 homolog; EC 3.6.4.10; Spermatogenesis-associated factor protein; Spermatogenesis-associated protein 5FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8NB90
Background Information
  • Uniprot Id

    Q8NB90

  • Target Species

    Human

  • Target Name

    AFG2A

  • Target Full Name

    ATPase family gene 2 protein homolog A

  • Target Function

    ATP-dependent chaperone which uses the energy provided by ATP hydrolysis to generate mechanical force to disassemble protein complexes. May be involved in morphological and functional mitochondrial transformations during spermatogenesis.

  • Target Involvement

    Epilepsy, hearing loss, and mental retardation syndrome (EHLMRS)

  • Target Subcellular Location

    Cytoplasm. Mitochondrion. Cytoplasm, cytoskeleton, spindle.

  • Target Protein Families

    AAA ATPase family, AFG2 subfamily

  • Target Synonyms

    SPATA5; AFG2; SPAF; ATPase family protein 2 homolog; EC 3.6.4.10; Spermatogenesis-associated factor protein; Spermatogenesis-associated protein 5

Inquire Recombinant Human Spermatogenesis-associated protein 5 (SPATA5), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification